IL-23 promotes tumour incidence and growth - Wikidata - wikimedia - TriplyDB

IL-23 promotes tumour incidence and growth

IL-23 promotes tumour incidence and growth

http://www.wikidata.org/entity/Q28239522

about

Tumor dormancy: potential therapeutic target in tumor recurrence and metastasis prevention microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer The structure of interleukin-23 reveals the molecular basis of p40 subunit sharing with interleukin-12 A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses T helper 17 cells promote cytotoxic T cell activation in tumor immunity Tumor-specific Th17-polarized cells eradicate large established melanoma Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo The interplay between the microbiome and the adaptive immune response in cancer development The roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity Cytokine-Induced Modulation of Colorectal Cancer Regulation of Natural Killer Cell Function by STAT3 Association of IL-23R Polymorphisms (rs6682925, rs10889677, rs1884444) With Cancer Risk: A PRISMA-Compliant Meta-Analysis Targeting the tumor microenvironment: JAK-STAT3 signaling Interleukin-27: balancing protective and pathological immunity Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues Role of cytokines and Toll-like receptors in the immunopathogenesis of Guillain-Barré syndrome Immunity, Inflammation, and Cancer Ustekinumab in treatment of Crohn's disease: design, development, and potential place in therapy Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer The Plasmodium circumsporozoite protein, a novel NF-κB inhibitor, suppresses the growth of SW480 Interleukin-23 promotes the epithelial-mesenchymal transition of oesophageal carcinoma cells via the Wnt/β-catenin pathway IL-17 mediated inflammation promotes tumor growth and progression in the skin Cancer: evolutionary, genetic and epigenetic aspects STATs in cancer inflammation and immunity: a leading role for STAT3 The dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape.Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants Papilloma-pseudovirus eradicates intestinal tumours and triples the lifespan of ApcMin/+ mice.Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17.Naturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer Drugs.High IL-17 expression is associated with an unfavorable prognosis in thyroid cancer Glucocorticoid-induced reversal of interleukin-1β-stimulated inflammatory gene expression in human oviductal cells.Membrane-bound IL-12 and IL-23 serve as potent mucosal adjuvants when co-presented on whole inactivated influenza vaccines.Lymphocytes in cancer development: polarization towards pro-tumor immunity Role of interleukin-23 circulating levels increase in resected colorectal cancer before and after chemotherapy: preliminary data and future perspectives.Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal.Potential role of ustekinumab in the treatment of chronic plaque psoriasis IL-23/IL-27 Ratio in Peripheral Blood of Patients with Breast Cancer.Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?

P2860

Q21195742-2663BFD1-3750-4B20-BD21-03381973E9DF Q24299080-F9F7D8DE-A298-4260-8194-401E662C8810 Q24321297-535D96BC-DFFD-4551-A75A-9CA26A162097 Q24630221-7AE011C8-8827-4497-A9B4-8BFA6970F0E4 Q24646584-28D0FC5E-AD96-49AB-8091-5F0A32FEDA66 Q24648032-7B2B1708-7D56-4957-AE57-4B18DDA119C1 Q24675613-4C715BB8-3341-4E80-A2CE-1F3B77D3A00A Q26745703-3B31280B-873A-4E9F-8CE0-F8ADAF6AE409 Q26750673-003F36BD-3D32-4AE5-9963-14EA93821D41 Q26752374-41E2021D-B8E6-4165-A86A-0DD7C34C794A Q26752551-05D1CF8E-1101-4F65-A6FA-3559A8637D97 Q26771567-B03742C0-E18E-44FE-9C04-0FEBC4102FDC Q26825658-7A4152FA-14B8-4689-B6BB-5EDD6A2678FF Q26830400-3F64D732-2D98-4B95-9357-EB7ED6DB4F9A Q27003907-B62645A1-19DC-4105-9E51-F995647B08A3 Q27027324-4308EDA4-A573-46BA-9FA4-6FC8A0BCC46E Q27861048-2C9FC167-DE35-4AA5-AA2E-750BB75DF659 Q28067631-D89533F2-DB76-4899-B723-3F4FE5D6F889 Q28081811-4F9D068C-2337-4B54-AECF-F3C463A4D36E Q28267996-3B615E8D-82DD-493D-93ED-A24C23CF889F Q28268422-54C34226-8761-48BB-8604-6B7C2711A52F Q28388763-D78F96CD-107C-43FE-8BE3-FF2AD6D82814 Q28480915-3B6611CC-B693-4B7B-9BE3-660FF5A7A9ED Q28728960-BD9950B7-7C7C-49BB-935B-983DAF111A88 Q29547203-2E46CD48-4357-45E4-BD31-9D1386F687F6 Q30317628-F73319DC-CF96-4BCE-A695-ECDD73E928E2 Q30431530-17A64D11-24B1-41CF-B1C9-1EABA8672DB4 Q33296981-0CBE69D2-9C00-42A5-9F3B-E04B614E5C2E Q33571959-7397AE24-1608-4FF7-A22F-787BD9924CBA Q33590409-A3E88FB6-C908-4F48-9B37-F50EF085F248 Q33593041-B1900959-94DF-4815-B9D6-BF0EA9301A04 Q33597831-EC2F302E-59A7-4295-B69F-D6F0DD339CAF Q33645478-93752AA1-B63B-43AB-A62C-C8EA9505BDDE Q33676505-DB2A5B41-804E-4E2B-9715-B6187C56AD53 Q33712435-A1C7312E-3476-43D8-9FAC-7DB6992D7270 Q33814452-5C7264F3-B207-442A-8A04-D22B843E337A Q33816141-E4B16F4A-F007-4368-B772-0E6B504AD319 Q33892602-65EA8282-2628-415D-A43E-80FF71605B99 Q33907311-44CEB93B-463A-4E07-B615-C94FE9A3B5B7 Q33921803-0AB2D443-B36B-4664-8D2E-5FFC2B7379FB

P2860

IL-23 promotes tumour incidence and growth

http://www.wikidata.org/entity/Q28239522

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

IL-23 promotes tumour incidence and growth

@ast

IL-23 promotes tumour incidence and growth

@en

IL-23 promotes tumour incidence and growth

@nl

type

label

IL-23 promotes tumour incidence and growth

@ast

IL-23 promotes tumour incidence and growth

@en

IL-23 promotes tumour incidence and growth

@nl

prefLabel

IL-23 promotes tumour incidence and growth

@ast

IL-23 promotes tumour incidence and growth

@en

IL-23 promotes tumour incidence and growth

@nl

P1433

Q28239522-EBB60CC6-64E1-4F6B-A292-AD18B49C7EC4

P1476

Q28239522-41FAD1F3-5272-4B75-AD5B-833420C3B5EE

P2093

Q28239522-08BE4363-AE7A-4269-B035-AFE5BB31D44E

Q28239522-2297BE68-4EB3-4D00-848C-076AF4CA0CD3

Q28239522-276A9F54-E166-463C-B855-83A2F5F00B18

Q28239522-48DE4B39-2EFD-48EB-92CF-58248D498DD4

Q28239522-86E2CAF6-4D5C-4AFC-9CF9-C67C8DC0211D

Q28239522-AD7DB795-A7AE-4672-9614-00EF9C173F29

Q28239522-C6036388-ADE3-484C-8E19-55149E504F9E

Q28239522-D7BDB59C-E028-4230-B5B5-06D6B09A059F

Q28239522-E4DA86D6-15D2-49D8-B009-545860A0849B

Q28239522-ECE648E1-76B8-425F-B934-9168A2B2832F

P2860

Q28239522-005B278B-F401-46EF-A3DE-5AD836A6B357

Q28239522-024C0FC3-725F-4EE9-8E81-40C6C4703361

Q28239522-1CC9F496-8AF5-4300-AC54-3DDB59E5A53A

Q28239522-22336C5D-1284-445C-9010-472CA6300653

Q28239522-231ACFEE-33A5-4796-8A4B-F315B8C6BFF5

Q28239522-2E8A2D84-EABF-4DBE-934F-B34E93F3C979

Q28239522-31CDC5E0-F6B3-4969-BC25-E521EB444CB3

Q28239522-3FC1006C-C3E6-4F36-9107-9BCDD4BC2815

Q28239522-47335DB3-5D13-4A44-A56B-6C42F22F2B6D

Q28239522-5A60E8ED-0E77-4B02-A94E-5826479A7745

P2888

Q28239522-DDCA16EC-4917-4099-A1BE-FF8E21C7F825

P304

Q28239522-FB57EC7C-CBAF-455D-A40F-AC47553435F3

P31

Q28239522-2FD01911-F5FC-4632-BDA6-4902A4F246C9

P3181

Q28239522-86F24031-6C6D-48D7-9484-077C7B63CF71

P356

Q28239522-5BCDDADD-73FB-4797-9957-D0BFE7B7C904

P407

Q28239522-558D5535-761A-4AF9-88FC-66018A7AF74E

P433

Q28239522-E62EC5C5-7A29-4463-B470-EDD10782FB65

P478

Q28239522-3FB6DC1F-F034-4A49-BB21-950204A7855F

P577

Q28239522-0689CC79-3193-4616-BFDC-44357F682587

P5875

Q28239522-8C191AB2-F3D3-473E-A068-DCD553C4DAEB

P6179

Q28239522-A9D7E026-4187-4128-8413-D15462BEEA93

P698

Q28239522-BA7F060A-D44C-4BD1-B0CA-55813F9EE048

P3181

P356

P1433

P1476

IL-23 promotes tumour incidence and growth

@en

P2093

Beth Basham

http://www.w3.org/2001/XMLSchema#string

Jeanine D Mattson

http://www.w3.org/2001/XMLSchema#string

John L Langowski

http://www.w3.org/2001/XMLSchema#string

Kathy Smith

http://www.w3.org/2001/XMLSchema#string

Lingling Wu

http://www.w3.org/2001/XMLSchema#string

Martin Oft

http://www.w3.org/2001/XMLSchema#string

Robert A Kastelein

http://www.w3.org/2001/XMLSchema#string

Taiying Chen

http://www.w3.org/2001/XMLSchema#string

Terrill McClanahan

http://www.w3.org/2001/XMLSchema#string

Xueqing Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12

A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R

Inflammation and cancer

Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris

Inflammation and cancer: back to Virchow?

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

Antitumor and antimetastatic activity of IL-23

Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

P2888

P304

461-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

685218

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NATURE04808

http://www.w3.org/2001/XMLSchema#string

P407

P433

7101

http://www.w3.org/2001/XMLSchema#string

P478

442

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7093511

http://www.w3.org/2001/XMLSchema#string

P6179

1050989342

http://www.w3.org/2001/XMLSchema#string

P698

16688182

http://www.w3.org/2001/XMLSchema#string